PMID: 16520651Mar 8, 2006Paper

Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2)

Anti-cancer Drugs
Abdelhakim Ahmed-BelkacemAttilio Di Pietro

Abstract

Breast cancer resistance protein (BCRP/ABCG2) belongs to the ATP-binding cassette (ABC) transporter superfamily. It is able to efflux a broad range of anti-cancer drugs through the cellular membrane, thus limiting their anti-proliferative effects. Due to its relatively recent discovery in 1998, and in contrast to the other ABC transporters P-glycoprotein (MDR1/ABCB1) and multidrug resistance-associated protein (MRP1/ABCC1), only a few BCRP inhibitors have been reported. This review summarizes the known classes of inhibitors that are either specific for BCRP or also inhibit the other multidrug resistance ABC transporters. Information is presented on structure-activity relationship aspects and how modulators may interact with BCRP.

References

Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·L A DoyleD D Ross
Oct 19, 2000·Journal of the National Cancer Institute·J W JonkerA H Schinkel
Jan 5, 2001·Bioorganic & Medicinal Chemistry Letters·A van LoevezijnG J Koomen
Jul 5, 2001·Biochemical and Biophysical Research Communications·C OzvegyB Sarkadi
Jan 24, 2002·Journal of Bioenergetics and Biomembranes·S E BatesT Litman
Apr 3, 2002·Japanese Journal of Cancer Research : Gann·Yasuo ImaiYoshikazu Sugimoto
Nov 15, 2002·Cancer Biology & Therapy·Arthur B Pardee
Oct 21, 2003·International Journal of Cancer. Journal International Du Cancer·Holger WoehleckeHermann Lage
Nov 18, 2003·International Journal of Cancer. Journal International Du Cancer·Ken ShiozawaShigeru Kohno
Mar 10, 2004·The Journal of Pharmacology and Experimental Therapeutics·Anshul GuptaQingcheng Mao
Mar 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hans MindermanMaria R Baer
Mar 24, 2004·Integrative Cancer Therapies·Christopher G LisWilliam J M Hrushesky
Mar 30, 2004·Biochemical and Biophysical Research Communications·Hiran C CoorayMargery A Barrand
Apr 13, 2004·The Journal of Pharmacology and Experimental Therapeutics·Susan E BatesYves Pommier
Apr 23, 2004·Molecular Pharmacology·Shuzhong ZhangMarilyn E Morris
May 25, 2004·Molecular Pharmacology·Csilla Ozvegy-LaczkaBalázs Sarkadi
May 29, 2004·FEBS Letters·Balázs SarkadiAndrás Váradi
Jun 2, 2004·International Journal of Cancer. Journal International Du Cancer·Megumi YoshikawaShinzo Tanabe
Oct 20, 2004·Cancer Research·Clinton F StewartPeter J Houghton
Mar 25, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Misbah QadirMaria R Baer
May 24, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xiao-Fei ZhouMarilyn E Morris
Jun 9, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Csilla Ozvegy-LaczkaBalázs Sarkadi

❮ Previous
Next ❯

Citations

Jul 4, 2012·Cancer Metastasis Reviews·Darshni ViraEri S Srivatsan
Jan 19, 2008·Pharmaceutical Research·Qingcheng Mao
Dec 15, 2011·Journal of Medicinal Chemistry·Glaucio ValdameriAttilio Di Pietro
Jul 8, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Souzan B YanniPieter P Annaert
Jun 8, 2011·Radiation Oncology·Thomas Efferth, Peter Langguth
Feb 9, 2013·PloS One·Yue-Li SunZhe-Sheng Chen
Jul 28, 2011·OncoTargets and Therapy·Pham Van PhucPhan Kim Ngoc
Oct 9, 2012·Advanced Drug Delivery Reviews·Margarida EstudanteLeslie Z Benet
May 3, 2008·Organic & Biomolecular Chemistry·Elisa BarileVirginia Lanzotti
Nov 26, 2015·Expert Opinion on Drug Metabolism & Toxicology·Ágota ApátiBalázs Sarkadi
Apr 17, 2012·World Neurosurgery·Ryosuke Yamada, Ichiro Nakano
Jan 18, 2012·Biochemical Pharmacology·Karthika NatarajanDouglas D Ross
May 17, 2011·Bioorganic & Medicinal Chemistry Letters·Cristian Ochoa PuentesBurkhard König
Nov 26, 2009·Bioorganic & Medicinal Chemistry Letters·Anne PickMichael Wiese
Mar 24, 2009·European Journal of Medicinal Chemistry·Sergio Mares-SámanoJeffrey Penny
Jan 13, 2009·Advanced Drug Delivery Reviews·E NicolleA Di Pietro
Jul 5, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yi HanPui Lai Ee
Oct 30, 2007·Bioorganic & Medicinal Chemistry·Xiao-Ling LiuMei-Lin Go
Feb 24, 2007·Bioorganic & Medicinal Chemistry·Ahcene BoumendjelAttilio Di Pietro
Aug 17, 2014·Biochimica Et Biophysica Acta·Jennifer GallusMichael Wiese
Jul 16, 2010·ChemMedChem·Anne PickMichael Wiese
Oct 12, 2010·Chemical Biology & Drug Design·Abdolhossein ZarrinRamin Miri
Nov 15, 2012·ChemMedChem·Federico MarighettiMichael Wiese
Mar 5, 2015·ChemMedChem·Federico MarighettiMichael Wiese
Oct 13, 2009·Fundamental & Clinical Pharmacology·Hind SassiAnne Hulin
Aug 22, 2015·Future Medicinal Chemistry·Kapil Juvale, Michael Wiese
Jul 5, 2016·European Journal of Medicinal Chemistry·Amanda do Rocio Andrade PiresBasile Pérès
Jul 10, 2013·Molecular Pharmaceutics·Anne Sophie GrandvuinetBente Steffansen
Dec 23, 2016·Medicinal Research Reviews·Diana Peña-SolórzanoCristian Ochoa-Puentes
Dec 17, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ikumi WashioIkumi Tamai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.